Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
38 hedge funds and large institutions have $15.1M invested in Applied Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.27% less ownership
Funds ownership: 47.22% → 40.95% (-6.3%)
12% less capital invested
Capital invested by funds: $17.1M → $15.1M (-$2.07M)
14% less funds holding
Funds holding: 44 → 38 (-6)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$1.08M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$272K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$256K |
| 4 |
PVI
Pura Vida Investments
New York
|
+$80.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.54M |
| 2 |
O
OrbiMed
New York
|
-$948K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$791K |
| 4 |
BlackRock
New York
|
-$185K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$183K |
APLT Hedge Fund Activity: Q4 2022 in Review
38 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q4 2022, worth a combined $15.1M — down 12% from $17.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of APLT and 5 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 6 added.
The largest buyer was Knoll Capital Management, adding an estimated $1.08M. The largest seller was Alyeska Investment Group, cutting an estimated $1.54M.
- 38 institutional investors held Applied Therapeutics (APLT) as of Q4 2022, down from 44 in Q3 2022.
- Funds reported $15.1M of Applied Therapeutics stock for Q4 2022, down 12% quarter-over-quarter.
- 5 funds opened new Applied Therapeutics positions in Q4 2022 and 11 closed out, a net change of -6 holders.
- The largest Applied Therapeutics buyer in Q4 2022 was Knoll Capital Management, an estimated $1.08M added.
- The largest Applied Therapeutics seller in Q4 2022 was Alyeska Investment Group, an estimated $1.54M sold.
Based on aggregated 13F filings for Q4 2022.